Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
CNBC - 2024-05-01T10:31:53.000Z

The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.

In related news

Johnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuits
Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovarian cancer, the company said Wednesday in a statement. The deal would allow it to resolve the lawsuits through a third bankruptcy filing of a subsidiary company. It will begin a three-month voting period in hopes of reaching consensus on a settlement of all current and future ovarian cancer claims....
- Related Articles
- In News
- From CNN
- 2024-05-01T13:36:06.595Z
J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer. The lawsuits filed against J&J had alleged its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs. The claims contributed to drop in J&J’s sales of baby powder, prompting the...
- Related Articles
- In News
- From Yahoo Finance
- 2024-05-01T11:15:17.000Z
Johnson & Johnson proposes $6.5bn settlement of talc cancer lawsuits
Deal would resolve tens of thousands of lawsuits alleging company's baby powder causes ovarian cancer.
- Related Articles
- In News
- From The Guardian
- 2024-05-01T12:25:13.000Z

In related news

Johnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuits

J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits

Johnson & Johnson proposes $6.5bn settlement of talc cancer lawsuits